When an inspector walks into a pharmacy, the first minutes set the tone for everything after. The regulations do not script those minutes, but they do define what must be on the premises and what the inspector is entitled to see, which makes the first questions predictable. This guide orders those questions by the documents that answer them, cites the rule behind each, and says what a good answer looks like. The ordering is our own editorial judgment; the rules cited are the primary sources. For the full visit in sequence, see our companion DEA inspection walkthrough.
Before the questions: the notice and the consent
An inspection begins with paperwork. 21 CFR 1316.06 lists what the notice of inspection (Form 82) must contain: the name and title of the owner, operator or agent in charge, the premises name and address, the date and time, a statement that the notice is given under section 510 of the Controlled Substances Act (21 U.S.C. 880) with the pertinent text reproduced, and the inspector's signature (eCFR, 21 CFR 1316.06).
Under 21 CFR 1316.08 a warrant is not required if informed consent is obtained, and where possible the consent is a written statement signed by the owner, operator or agent in charge and witnessed by two persons. It must say the person was told of the right to refuse, that incriminating items found may be seized and used in a prosecution, that a notice of inspection was given, that the consent is voluntary, and that it may be withdrawn at any time during the inspection (eCFR, 21 CFR 1316.08). Know who in your pharmacy is the agent in charge, and make sure that person has read this section before the day it matters. Whether to consent, and how, is a question for your counsel, not for a blog post.
Question 1: Who is responsible here?
The first thing you hand over is a name. The inspection notice is addressed to the agent in charge, so you need one on every shift. Write down, ahead of time, who that is when the pharmacist in charge is out. The related question follows quickly: who has access to controlled substances? 21 CFR 1301.76(a) bars employing in such a role anyone convicted of a controlled-substance felony or who has had a DEA registration denied, revoked or surrendered for cause (eCFR, 21 CFR 1301.76). A staff list with each person's access level, and a record of how you screened them, is the answer.
Question 2: Where is your current inventory?
21 CFR 1304.11 requires an inventory that is "a complete and accurate record of all controlled substances on hand," kept at the registered location, taken at least every two years, and showing whether it was taken at the opening or the close of business. Schedule II containers get an exact count. Opened containers of Schedules III-V get an estimated count unless the container holds more than 1,000 tablets or capsules, in which case the count must be exact (eCFR, 21 CFR 1304.11).
A good answer is a dated, signed inventory in a binder or file that anyone on shift can find, with the opening-or-close notation visible. A weak answer is "the pharmacist has it at home." Our inventory requirements guide walks through the count rules.
Question 3: Show me your records
21 CFR 1304.04 requires records to be kept for at least two years from the date of the inventory or record. For pharmacies it requires Schedule I and II inventories and records to be kept separate from other pharmacy records, with Schedule II paper prescriptions in a separate file at the registered location (eCFR, 21 CFR 1304.04). The test is retrieval time. If an inspector asks for a particular drug's receipts and you can produce them while they watch, you have answered more than the question. If it takes an hour, you have shown that the system depends on one person's memory. See the recordkeeping guide.
Question 4: What have you lost, and what did you do about it?
This is where discrepancies surface. Under 21 CFR 1301.76(b) the registrant must notify the DEA Field Division Office in writing of theft or significant loss within one business day of discovery and file a complete DEA Form 106 within 45 days. Have the Form 106 file ready, and have the internal notes for any discrepancy that you decided was not a significant loss, with the reasoning. The decision not to report is the one an inspector is most likely to test. Use our Form 106 guide and the one-business-day explainer to build that file.
Question 5: How do you protect the stock?
21 CFR 1301.71(a) requires "effective controls and procedures to guard against theft and diversion," and the fifteen factors in (b) are the considerations the Administrator may weigh. They include key-control and combination-lock control, alarm systems, supervision of employees with access, procedures for visitors and maintenance personnel, and the adequacy of the registrant's system for monitoring receipt, distribution and disposition of controlled substances (eCFR, 21 CFR 1301.71). Notice that the last item is about monitoring, not hardware. A new lock does not answer "how would you know?" A monthly reconciliation report does. Our factor-by-factor guide maps each of the fifteen to a document you can show.
Question 6: What do your employees know?
21 CFR 1301.91 places on an employee who knows of a coworker's diversion an obligation to report it to a responsible security official, and requires the employer to keep the report confidential and to inform all employees of the policy. A failure to report may be considered when deciding whether the employee may continue working in a drug security area (eCFR, 21 CFR 1301.91). The document that answers this question is a signed acknowledgment from each employee. If you have none, create the policy and collect signatures this week. Our guide to reporting diversion has staff-facing guidance.
Question 7: And for prescriptions: how do you decide to fill?
For a pharmacy, the questions end where the dispensing rule begins, with 21 CFR 1306.04(a): a prescription must be issued for a legitimate medical purpose in the usual course of professional practice, and a corresponding responsibility rests with the pharmacist who fills it (eCFR, 21 CFR 1306.04). The answer is a written process for what you do with a prescription that raises doubt, and notes showing it was followed. A 2026 Fifth Circuit decision, Neumann's Pharmacy v. DEA, narrowed the federal liability standard in that circuit to actual knowledge or willful blindness, according to one law-firm analysis, and that analysis says it does not change state-law duties (Harris Beach Murtha). Keep the process either way.
A one-page readiness sheet
Put the seven answers on one page that lives next to the inventory: the agent in charge and a backup; where the current inventory is; where Schedule II records and the separate prescription file are; the Form 106 file; the security procedures and who reviews them; the employee acknowledgments; and the written process for doubtful prescriptions. Review it quarterly and after any staffing change. State boards may ask their own questions; our state pages link each board's rules.
To find which of the seven you cannot yet answer, run the community pharmacy self-assessment.
Sources: 21 CFR 1301.71, 1301.76, 1301.91, 1304.04, 1304.11, 1306.04, 1316.06 and 1316.08 (eCFR, current); Harris Beach Murtha analysis of Neumann's Pharmacy, L.L.C. v. DEA, No. 25-60068 (5th Cir. Feb. 13, 2026). Educational content, not legal advice.